Cargando…
MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents—A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives
Mesenchymal stem cells (MSCs) are considered to be a powerful tool in the treatment of various diseases. Scientists are particularly interested in the possibility of using MSCs in cancer therapy. The research carried out so far has shown that MSCs possess both potential pro-oncogenic and anti-oncoge...
Autores principales: | Szewc, Monika, Radzikowska-Bűchner, Elżbieta, Wdowiak, Paulina, Kozak, Joanna, Kuszta, Piotr, Niezabitowska, Ewa, Matysiak, Joanna, Kubiński, Konrad, Masłyk, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911180/ https://www.ncbi.nlm.nih.gov/pubmed/35269887 http://dx.doi.org/10.3390/ijms23052745 |
Ejemplares similares
-
Quinazoline Derivatives as Potential Therapeutic Agents in Urinary Bladder Cancer Therapy
por: Wdowiak, Paulina, et al.
Publicado: (2021) -
The Link between Protein Kinase CK2 and Atypical Kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2017) -
Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1
por: Kubiński, Konrad, et al.
Publicado: (2016) -
CX-4945: the protein kinase CK2 inhibitor and anti-cancer drug shows anti-fungal activity
por: Masłyk, Maciej, et al.
Publicado: (2017) -
New Supramolecular Drug Carriers: The Study of Organogel Conjugated Gold Nanoparticles
por: Kowalczuk, Joanna, et al.
Publicado: (2021)